Williams KJ - Search Results

1

Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy.

Silk JD, Hermans IF, Gileadi U, Chong TW, Shepherd D, Salio M, Mathew B, Schmidt RR, Lunt SJ, Williams KJ, Stratford IJ, Harris AL, Cerundolo V. Silk JD, et al. Among authors: williams kj. J Clin Invest. 2004 Dec;114(12):1800-11. doi: 10.1172/JCI22046. J Clin Invest. 2004. PMID: 15599405 Free PMC article.

2

Role of thymidine phosphorylase in an in vitro model of human bladder cancer invasion.

Jones A, Fujiyama C, Turner K, Cranston D, Williams K, Stratford I, Bicknell R, Harris AL. Jones A, et al. J Urol. 2002 Mar;167(3):1482-6. J Urol. 2002. PMID: 11832774

3

Bioreductive and gene therapy approaches to hypoxic diseases.

Jaffar M, Williams KJ, Stratford IJ. Jaffar M, et al. Among authors: williams kj. Adv Drug Deliv Rev. 2001 Dec 17;53(2):217-28. doi: 10.1016/s0169-409x(01)00228-9. Adv Drug Deliv Rev. 2001. PMID: 11731027 Review.

4

Hypoxia and oxidative stress. Tumour hypoxia--therapeutic considerations.

Williams KJ, Cowen RL, Stratford IJ. Williams KJ, et al. Breast Cancer Res. 2001;3(5):328-31. doi: 10.1186/bcr316. Epub 2001 Aug 7. Breast Cancer Res. 2001. PMID: 11597323 Free PMC article. Review.

5

Combining bioreductive drugs and radiation for the treatment of solid tumors.

Stratford IJ, Williams KJ, Cowen RL, Jaffar M. Stratford IJ, et al. Among authors: williams kj. Semin Radiat Oncol. 2003 Jan;13(1):42-52. doi: 10.1053/srao.2003.50008. Semin Radiat Oncol. 2003. PMID: 12520463 Review.

6

Tirapazamine administered as a neoadjuvant to radiotherapy reduces metastatic dissemination.

Lunt SJ, Telfer BA, Fitzmaurice RJ, Stratford IJ, Williams KJ. Lunt SJ, et al. Among authors: williams kj. Clin Cancer Res. 2005 Jun 1;11(11):4212-6. doi: 10.1158/1078-0432.CCR-04-2162. Clin Cancer Res. 2005. PMID: 15930359 Free article.

7

Antiangiogenic, bioreductive and gene therapy approaches to the treatment of hypoxic tumours.

McNally VA, Patterson AV, Williams KJ, Cowen RL, Stratford IJ, Jaffar M. McNally VA, et al. Among authors: williams kj. Curr Pharm Des. 2002;8(15):1319-33. doi: 10.2174/1381612023394548. Curr Pharm Des. 2002. PMID: 12052210 Review.

8

Synthesis and enzymatic evaluation of pyridinium-substituted uracil derivatives as novel inhibitors of thymidine phosphorylase.

Murray PE, McNally VA, Lockyer SD, Williams KJ, Stratford IJ, Jaffar M, Freeman S. Murray PE, et al. Among authors: williams kj. Bioorg Med Chem. 2002 Mar;10(3):525-30. doi: 10.1016/s0968-0896(01)00309-1. Bioorg Med Chem. 2002. PMID: 11814838

9

Metabolic changes detected by in vivo magnetic resonance studies of HEPA-1 wild-type tumors and tumors deficient in hypoxia-inducible factor-1beta (HIF-1beta): evidence of an anabolic role for the HIF-1 pathway.

Griffiths JR, McSheehy PM, Robinson SP, Troy H, Chung YL, Leek RD, Williams KJ, Stratford IJ, Harris AL, Stubbs M. Griffiths JR, et al. Among authors: williams kj. Cancer Res. 2002 Feb 1;62(3):688-95. Cancer Res. 2002. PMID: 11830521

10

The hypoxia-selective cytotoxin NLCQ-1 (NSC 709257) controls metastatic disease when used as an adjuvant to radiotherapy.

Lunt SJ, Cawthorne C, Ali M, Telfer BA, Babur M, Smigova A, Julyan PJ, Price PM, Stratford IJ, Bloomer WD, Papadopoulou MV, Williams KJ. Lunt SJ, et al. Among authors: williams kj. Br J Cancer. 2010 Jul 13;103(2):201-8. doi: 10.1038/sj.bjc.6605753. Epub 2010 Jun 29. Br J Cancer. 2010. PMID: 20588272 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

627 results

Search Page